Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.

J Alzheimers Dis · 2025 · PMC12614907 · PMID 41004623

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nominally significantp < 0.05actually significant

Targeted metabolomics results Metabolomic profiling revealed 22 metabolites exhibiting nominally significant differences (p < 0.05) between AD and HC.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.